Analergine,
Antasten,
Antazoline,
Antazoline Hydrochloride,
Antazoline Phosphate,
Antazoline Phosphate (1:1),
Antistine,
Arithmin,
Hydrochloride, Antazoline,
Imidamine,
Phenazoline,
Phosphate, Antazoline,
Antazoline hydrochloride,
2508-72-7,
Antazoline HCl,
Fenazolina,
Histazine,
Phenazoline hydrochloride,
Antazoline (hydrochloride),
2-(N-Benzylanilinomethyl)-2-imidazoline hydrochloride,
Antazolinium chloratum,
Antistine hydrochloride,
UNII-FP8Q8F72JH,
EINECS 219-719-8,
FP8Q8F72JH,
MLS000028599,
2-Phenylbenzylaminomethylimidazoline hydrochloride,
MFCD00058145,
2-(N-Phenyl-N-benzylaminomethyl)imidazoline hydrochloride,
SMR000058731,
2-Imidazoline, 2-((N-benzylanilino)methyl)-, monohydrochloride,
DSSTox_CID_27762,
DSSTox_RID_82539,
DSSTox_GSID_47782,
2-(N-Benzylanilino)methyl-2-imidazoline, hydrochloride,
2-IMIDAZOLINE, 2-((N-BENZYLANILINO)METHYL)-, HYDROCHLORIDE,
N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline hydrochloride,
N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline,hydrochloride,
N-Benzyl-N-((4,5-dihydro-1H-imidazol-2-yl)methyl)aniline hydrochloride,
4,5-Dihydro-N-phenyl-N-(phenylmethyl)-1H-imidazole-2-methanamine hydrochloride,
SR-01000000255,
NCGC00016613-01,
(2-imidazolin-2-ylmethyl)phenylbenzylamine, chloride,
CAS-2508-72-7,
antazoline-hcl,
Antazoline hydrochloride [USP],
Phenazocine HCl,
N-benzyl-N-[(4,5-dihydro-1H-imidazol-2-yl)methyl]aniline hydrochloride,
Prestwick_82,
Phenazolinum (TN),
Antazolinehydrochloride,
N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline;hydrochloride,
Opera_ID_1387,
AC1L29OE,
Antazoline Hydrochloride,(S),
labotest-bb lt00134672,
MLS001148371,
MLS002153486,
MLS002222161,
REGID_for_CID_17275,
CHEMBL1256819,
DTXSID1047782,
CTK8B2946,
KS-00000VVI,
HMS1568D18,
HY-B1067,
Tox21_110524,
ANW-41427,
SBB057007,
AKOS015916586,
Tox21_110524_1,
AC-8174,
AN-8292,
CCG-220258,
CS-4623,
MCULE-4468873456,
VA10298,
NCGC00016613-10,
NCGC00180986-01,
AK154010,
LS-79573,
TR-011484,
A2132,
ST50993904,
SW196394-3,
A16411,
D07459,
2-(n-phenyl-n-benzyl-aminomethyl)-imidazoline hcl,
SR-01000000255-3,
SR-01000000255-6,
I14-51834,
2-(N-BENZYLANILINOMETHYL) IMIDAZOLINE HYDROCHLORIDE,
Antazoline Hydrochloride 1.0 mg/ml in Methanol (as free base),
benzyl-(4,5-dihydro-1h-imidazol-2-ylmethyl)-phenyl-amine hcl,
Antazoline hydrochloride, European Pharmacopoeia (EP) Reference Standard,
1H-Imidazole-2-methanamine, 4,5-dihydro-N-phenyl-N-(phenylmethyl)-, hydrochloride (1:1),
C17H20ClN3,
C17H19N3.HCl,
C17-H19-N3.Cl-H,
CID17275,
3,6-Dichloro-2-methoxybenzoic acid,
B1664,
2-(N-Benzylanilinomethyl)-2-imidazolinehydrochloride,
2-Imidazoline, 2-[(N-benzylanilino)methyl]-, monohydrochloride,
1H-Imidazole-2-methanamine, 4,5-dihydro-N-phenyl-N-(phenylmethyl)-, monohydrochloride,